Takeda Pharmaceutical
TAK
#494
Rank
C$70.86 B
Marketcap
C$22.43
Share price
-1.40%
Change (1 day)
11.30%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): C$4.49 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are C$29.86 Billion. , an increase over its 2024 earnings that were of C$3.07 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 C$4.58 B49.03%
2024 C$3.07 B-2.41%
2023 C$3.15 B-28.14%
2022 C$4.39 B-40.9%
2021 C$7.43 B78.24%
2020 C$4.16 B246.1%
2019 C$1.20 B-48.79%
2018 C$2.35 B-23.64%
2017 C$3.07 B21.7%
2016 C$2.53 B-253.01%
2015 -C$1.66 Billion-159.65%
2014 C$2.77 B13%
2013 C$2.45 B2.46%
2012 C$2.39 B-57.05%
2011 C$5.57 B-10.49%
2010 C$6.22 B-3.99%
2009 C$6.48 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.85 B 681.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$21.78 B 374.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$14.61 B 218.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.54 B 173.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.56 B 130.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$18.15 B 295.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.81 B 201.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-C$1.1 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
C$1.20 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India